We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

JPMorgan China Growth & Income Plc (JCGI) Ordinary 25p

Sell:450.00p Buy:454.00p 0 Change: 9.00p (1.94%)
Market closed Prices as at close on 24 January 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:450.00p
Buy:454.00p
Change: 9.00p (1.94%)
Market closed Prices as at close on 24 January 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:450.00p
Buy:454.00p
Change: 9.00p (1.94%)
Market closed Prices as at close on 24 January 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Objective

To provide long-term capital growth by investment in companies associated within Greater China. To invest in companies which are quoted on the stock exchanges of Hong Kong, it aims to outperform the MSCI China Index total return, with net dividends reinvested, in sterling terms. The number of investments in the Company will normally range between 45 and 85.
Security Weight
Tencent Holdings Ltd 10.17%
Meituan Class B 5.84%
Wuxi Biologics Cayman Inc Common Stock Usd 0.00001 4.24%
Contemporary Amperex Technology Co Ltd Class A 3.01%
Pinduoduo Inc ADR 2.90%
Alibaba Group Holding Ltd Ordinary Shares 2.67%
China Merchants Bank Co Ltd Class H 2.52%
Shanghai Baosight Software Co Ltd Class A 2.48%
Country Garden Services Holdings Co Ltd 2.37%
Sunny Optical Technology (Group) Co Ltd 2.24%
Sector Weight
Consumer Cyclical 25.58%
Technology 17.76%
Communication Services 15.93%
Healthcare 12.27%
Industrials 8.35%
Consumer Defensive 7.33%
Financial Services 4.65%
Real Estate 3.45%
Utilities 2.07%
Basic Materials 0.79%
Country Weight
China 94.69%
Switzerland 6.29%
Cayman Islands 4.24%
Netherlands 2.90%
Hong Kong 1.94%
Taiwan 1.56%
United States 1.05%
Curaçao 0.10%

Fee Structure

Management fee of 0.9% p.a. of NA. With effect from 1st April 2019, the management fee will be amended to 0.9% p.a. of NA.

Dividend Policy

Shareholders are reminded that the target annual dividend of 4% of the NAV of the Company on the last business day of the preceding financial year will be announced at the start of each financial year, to provide clarity to shareholders over the income stream they can expect during the following 12 months. This will be paid by way of four equal interim dividends on the first business day in March, June, September, and December.

ASSET SPLIT

Total number of holdings: 108.

Trust Manager

Howard Wang

Manager Bio

Howard Wang, managing director, is a country specialist for Greater China equities and head of the Greater China Team within the Emerging Markets and Asia Pacific (EMAP) Equities Team. Based in Hong Kong, he leads the Greater China-dedicated portfolio management teams in Hong Kong and Taipei and serves as the primary advisor for the investment team at J.P. Morgan Asset Management(JPMAM) Shanghai-based joint venture China International Fund Management (CIFM). He joined the Firm in 2005 after eight years at Goldman Sachs, where he was managing director and head of the Taipei office as well as an executive director with Goldman equities principal strategies team in Hong Kong. He began his career with Lazard in 1995 as a financial analyst in mergers & acquisitions in New York. Howard obtained a B.A. summa cum laude in economics from Yale University, where he was elected vice president of Phi Beta Kappa.

Board Of Directors

John MisselbrookChairman, Alexandra Mackesy, David Graham, Aditya Sehgal, Joanne Wong, Boi Tan Siew

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.